Skip to content
★ Sign in to follow
JL

Joseph Lambing

MyoKardia, Inc.
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€1.1M

Latest filing published 09 Jan 2019 for MyoKardia, Inc., €14k.

Filing timeline

BuySale
Joseph Lambing

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

Joseph Lambing: trading record in brief

Joseph Lambing discloses dealings in MyoKardia, Inc. to SEC (Form 4). Between 29 April 2016 and 7 January 2019, the trades on record add up to 15 filings.

The open-market record consists of 7 sales worth €1.1M, with no purchase. Besides market trades, the filings include 7 share grants and 1 option exercise.

The newest entry dates from 9 January 2019: a share grant of €14k, in MyoKardia, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Joseph Lambing

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    15,440 USD2SEC
    351 shares@ US$43.993.8% of flowCommon StockSEC:0000899243-19-000898:0
  • ◇
    See RemarksExecutivesMyoKardia, Inc.
    0SEC
    875 sharesCommon StockSEC:0000899243-19-000385:0
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    12,732 USD2SEC
    302 shares@ US$42.163.2% of flowCommon StockSEC:0000899243-18-031523:0
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    12,199 USD2SEC
    368 shares@ US$33.150.9% of flowCommon StockSEC:0000899243-18-014678:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    138,000 USD18SEC
    2,300 shares@ US$60.009.8% of flowCommon StockSEC:0000899243-18-005871:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    250,000 USD22SEC
    5,000 shares@ US$50.0018.2% of flowCommon StockSEC:0000899243-18-001092:0
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    13,040 USD2SEC
    1,128 shares@ US$11.561.0% of flowCommon StockSEC:0000899243-17-025396:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    225,000 USD19SEC
    5,000 shares@ US$45.0016.8% of flowCommon StockSEC:0000899243-17-020968:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    200,000 USD18SEC
    5,000 shares@ US$40.0014.9% of flowCommon StockSEC:0000899243-17-020485:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    125,000 USD18SEC
    5,000 shares@ US$25.009.3% of flowCommon StockSEC:0000899243-17-019943:0
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    150,000 USD18SEC
    5,000 shares@ US$30.0011.1% of flowCommon StockSEC:0000899243-17-019943:1
  • ▼
    See RemarksExecutivesMyoKardia, Inc.
    175,000 USD18SEC
    5,000 shares@ US$35.0013.0% of flowCommon StockSEC:0000899243-17-019943:2
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    12,587 USD2SEC
    1,135 shares@ US$11.091.0% of flowCommon StockSEC:0000899243-17-013320:0
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    12,668 USD2SEC
    1,263 shares@ US$10.031.0% of flowCommon StockSEC:0000899243-16-032645:0
  • ◆
    See RemarksExecutivesMyoKardia, Inc.
    10,481 USD2SEC
    1,233 shares@ US$8.500.8% of flowCommon StockSEC:0000899243-16-019415:0

15 of 15 declarations